Clinical

Dataset Information

0

Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib


ABSTRACT: This is a Phase 1 open-label, dose-escalation trial using "3+3" design, evaluating MM-151 co-administration with MM-121, MM-141, and trametinib at varying dose levels.

DISEASE(S): Squamous Cell Carcinoma Of Head And Neck,Squamous Cell Carcinoma Of The Head And Neck,Non-small Cell Lung Cancer,Colorectal Cancer,Cancer

PROVIDER: 2197256 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2119391 | ecrin-mdr-crc
| 2216131 | ecrin-mdr-crc
| 2708993 | ecrin-mdr-crc
| PRJNA255748 | ENA
| PRJNA316534 | ENA
2022-11-18 | PXD034846 | Pride
2022-11-18 | PXD034840 | Pride
2021-06-07 | GSE176242 | GEO
2023-06-19 | GSE152846 | GEO
2020-04-15 | GSE148648 | GEO